IGY Immune Technology to produce purified IgY products
The company plans to begin the production by the end of 2012. IGY Immune Technology chief executive officer Terry Dyck said, "The production of IgY at higher purity
Takeda and the Indonesian Government have announced a multi-phased collaboration to strengthen the country’s plasma ecosystem and expand access to plasma-derived medicinal products (PDMPs).